期刊文献+

淋巴结转移阴性进展期胃癌术后复发危险因素分析 被引量:12

Risk factors for recurrence after radical resection of node-negative advanced gastric cancer
原文传递
导出
摘要 目的 探讨淋巴结转移阴性进展期胃癌根治术后复发的危险因素.方法 收集2001年1月至2008年12月间在天津医科大学肿瘤医院行胃癌根治术治疗、经病理确诊为淋巴结转移阴性腺癌且随访资料完整的胃癌患者共270例,依据术后复发与否分为复发组与未复发组.回顾性分析这两组病例的临床病理资料,总结影响淋巴结转移阴性进展期胃癌根治术后复发的危险因素.结果 全组共复发45例(16.7%),复发时间2 ~68个月,生存时间5~ 87个月.复发组与未复发组患者在肿瘤直径、肿瘤浸润深度、清扫阴性淋巴结数目相比差异均具有统计学意义(均P<0.05).单因素分析显示:肿瘤直径、术后化疗与否与局部复发相关;肿瘤直径、浸润深度、术后化疗与远处转移相关.多因素分析显示,肿瘤直径、清扫阴性淋巴结数、浸润深度是全组复发的独立危险因素;浸润深度和清扫淋巴结数目是局部复发的独立危险因素;肿瘤直径、术后化疗是远处转移的独立危险因素.结论 对于T4期、肿瘤直径>4 cm的淋巴结转移阴性胃癌,标准的淋巴结清扫能减少局部复发,术后辅助化疗能降低远处转移复发率. Objective To evaluate the risk factors for recurrence of node-negative advanced gastric cancer(N0-AGC) after radical resection.Methods Data of 270 N0-AGC cases after curative intent resection were collected from 2001 to 2008 in Tianjin Cancer Hospital.There were 45 cases with postoperative recurrence.Univariate and multivariate analysis were applied to investigate risk factors for postoperative recurrence.Results The recurrence time was 2-68 months,the survival time was 5-87 months.Univariate analysis showed that tumor size,depth of tumor invasion,number of negative lymph nodes were associated with recurrence of N0-AGC.Multivariate analysis identified tumor size,depth of tumor invasion,number of negative lymph nodes as independent recurrence factors for entire cohort,depth of tumor invasion,number of negative lymph nodes were risk factors for locoregional recurrence.Tumor size,adjuvant chemotherapy for hematogenous metastasis.Conclusions For T4 stage,tumor diameter 〉4 cm advanced node-negative gastric cancer patients,extended lymphadenectomy was recommended to decrease locoregional recurrence,and adjuvant chemotherapy to reduce hematogenous spread.
出处 《中华普通外科杂志》 CSCD 北大核心 2013年第10期732-735,共4页 Chinese Journal of General Surgery
基金 国家重点研究发展计划973计划资助项目f2010CB529301)
关键词 胃肿瘤 肿瘤复发 局部 肿瘤转移 危险因素 Stomach neoplasms Neoplasm recurrence,local Neoplasm metastasis Risk factors
  • 相关文献

参考文献9

  • 1Kaposztas Z,Kalmar K,Cseke L,et al.Prognostic factors in the surgical treatment of gastric cancer - 10 years experience.Magy Seb,2007,60:71-78.
  • 2Chou HH,Kuo CJ,Hsu JT,et al.Clinicopathologic study of node-negative advanced gastric cancer and analysis of factors predicting its recurrence and prognosis.Am J Surg,2013,205:623-630.
  • 3Japanese classification of gastric carcinoma:3rd English edition.Gastric Cancer,2011,14:101-112.
  • 4Deng J,Liang H,Sun D,et al.Prognosis of gastric cancer patients with node-negative metastasis following curative resection:outcomes of the survival and recurrence.Can J Gastroenterol,2008,22:835-839.
  • 5Huang KH,Chen JH,Wu CW,et al.Factors affecting recurrence in node-negative advanced gastric cancer.J Gastroenterol Hepato1,2009,24:1522-1526.
  • 6王文清,叶超平,刘逢生,苏志明.胃癌术后复发的临床分析[J].中华普通外科杂志,2010,25(2):146-148. 被引量:13
  • 7王晓娜,倪姗姗,梁寒.淋巴结转移率对胃癌患者预后的影响[J].中华普通外科杂志,2008,23(6):411-415. 被引量:15
  • 8Kim JH,Park JM,Jung CW,et al.The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma.J Surg Oncol,2008,97:125-130.
  • 9Baiocchi GL,Tiberio GA,Minicozzi AM,et al.A multicentric Western analysis of prognostic factors in advanced,node-negative gastric cancer patients.Ann Surg,2010,252:70-73.

二级参考文献16

  • 1李凯,徐惠绵,陈峻青.淋巴结转移率和数量分级与胃癌预后及病理因素关系的研究[J].中华医学杂志,2005,85(30):2113-2116. 被引量:25
  • 2王舒宝,王俊.胃癌复发与转移的有关问题及综合治疗[J].中国普外基础与临床杂志,2006,13(1):9-11. 被引量:33
  • 3Inoue K, Nakane Y, Iiyama H, et al. The superiority of ratiobased lymph node staging in gastric carcinoma. Ann Surg Oncol, 2002,9:27-34.
  • 4Ichikura T, Ogawa T, Chochi K,et al. Minimum number of lymph nodes that should be examined for the International Union Against Cancer/American Joint Committee on Cancer TNM classification of gastric carcinoma. World J Surg, 2003,27: 330-333.
  • 5Kunisaki C, Makino H, Akiyama H, et al. Clinical significance of the metastatic lymph-node ratio in early gastric cancer. J Gastrointest Surg,2008,12,542-549.
  • 6Nitti D, Marchet A, Olivieri M, et al. Ratio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience. Ann Surg Oncol, 2003, 10 : 1077-1085.
  • 7Bando E, Yonemura Y, Taniquchi K, et al. Outcome of ratio lymph node metastasis in gastric carcinoma. Ann Surg Oncol, 2002,9:775-784
  • 8Ikequchi M, Oka S, Gomyo Y, et al. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer. Anticancer Res, 2000,20:1285-1259.
  • 9Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery : morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group Study 9501. J Clin Oncol, 2004,22:2767-2773.
  • 10Samson PS, Escovidal LA, Yrastorza SG, et al. Re-study of gastric cancer:analysls of outcome. World J Surg,2002 ,26 :428-433.

共引文献26

同被引文献73

引证文献12

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部